Delivery Order SPE2DB22D1202-SPE2DB25FUNV6
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$29K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $45,255.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots.
The contract is a Firm Fixed Price Delivery Order with a completion date of December 20, 2024. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $13,987.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Firm Fixed Price Delivery Order with a Period of Performance through November 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $12,551.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has an ultimate completion date of November 22, 2024, and is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition.
AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,241 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has an ultimate completion date of October 23, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award, valued at $19,711.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FZ35M) for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots.
The contract has an ultimate completion date of December 4, 2024 and is a firm fixed-price agreement. It is not designated as a set-aside contract,...
This federal contract award, valued at $7,441.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots.
The contract has an ultimate completion date of August 12, 2024 and is a delivery order with a firm fixed price pricing type. This award is not designated as a set-aside contract....
This federal contract award, valued at $14,991.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a prescription medication used to treat and prevent blood clots.
The contract is a Firm Fixed Price Delivery Order with a period of performance through November 2024. It is not designated as a set-aside contract, indicating open...
This federal contract award, valued at $13,847.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Eliquis 5 mg tablets, a medication used for the treatment of cardiovascular conditions. The contract has an ultimate completion date of July 28, 2023, and is a firm fixed-price contract type. This contract award is associated with a...
This federal contract award, valued at $36,849.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5mg tablets, a medication used to treat and prevent certain types of blood clots. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 20, 2022. This award is not designated as a set-aside contract....
This federal contract award, valued at $2,670.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots.
The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...